KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS$1.16B
Small CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaKIRKLAND330 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jul 14, 2026
11dMarket Overview
Stock performance and key metrics
KMTS News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
KMTS Earnings Report
Jul 14, 2026Confirmed
EPS Est: $-0.59 | FQ end 2026-04 | Call: 2026-07-14 15:30:00
How KMTS's past catalysts played out
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is KESTRA MEDICAL TECHNOLOGIES, LTD.'s next FDA catalyst?→
KESTRA MEDICAL TECHNOLOGIES, LTD.'s (KMTS) next tracked catalyst is a Earnings expected July 14, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track KMTS biotech catalysts?→
Add KMTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow KESTRA MEDICAL TECHNOLOGIES, LTD.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply